Compare DERM & STRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DERM | STRS |
|---|---|---|
| Founded | 2014 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.3M | 220.4M |
| IPO Year | 2021 | 1994 |
| Metric | DERM | STRS |
|---|---|---|
| Price | $6.24 | $19.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.67 | N/A |
| AVG Volume (30 Days) | ★ 157.2K | 96.3K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 34.72 | ★ 512.50 |
| EPS | N/A | ★ 0.82 |
| Revenue | ★ $61,858,000.00 | $29,914,000.00 |
| Revenue This Year | $39.72 | N/A |
| Revenue Next Year | $63.24 | N/A |
| P/E Ratio | ★ N/A | $24.00 |
| Revenue Growth | ★ 10.20 | N/A |
| 52 Week Low | $4.31 | $15.35 |
| 52 Week High | $9.56 | $32.93 |
| Indicator | DERM | STRS |
|---|---|---|
| Relative Strength Index (RSI) | 41.81 | 15.32 |
| Support Level | $5.80 | $18.51 |
| Resistance Level | $6.59 | $20.57 |
| Average True Range (ATR) | 0.37 | 1.01 |
| MACD | -0.13 | -0.14 |
| Stochastic Oscillator | 17.93 | 3.07 |
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the entitlement, development, management, leasing, and sale of multi-family and single-family residential and commercial real estate properties in the Austin, Texas area and other select markets in Texas. The company operates in two reportable segments: Real Estate Operations and Leasing Operations. Maximum revenue is generated from the Leasing Operations segment, which involves the leasing of commercial and residential properties developed by the company. The Real Estate Operations segment comprises properties under various stages of development: developed for sale, under development, and available for development.